CONMED Corporation provided earnings guidance for the full year 2022. For the year 2022, the company expects full-year 2022 revenue in the range of $1.075 billion to $1.125 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.13 USD | -0.06% | -5.70% | -38.76% |
Jun. 17 | Conmed Insider Sold Shares Worth $287,280, According to a Recent SEC Filing | MT |
May. 22 | CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.76% | 2.07B | |
-3.33% | 185B | |
-1.69% | 105B | |
-2.03% | 68.9B | |
+14.56% | 46.41B | |
-6.52% | 46.16B | |
+5.36% | 40.75B | |
+20.10% | 31.11B | |
+11.60% | 24.26B | |
-6.04% | 23.94B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Provides Earnings Guidance for the Full Year 2022